New era begins at Merck as pandemic cuts Q1 sales, profit By LINDA A. JOHNSON - Associated Press Shares
U.S. health panel urges restarting Johnson & Johnson COVID-19 vaccinations By Shen Wu Tan - The Washington Times Shares
US to resume J&J COVID vaccinations despite rare clot risk By LAURAN NEERGAARD and MIKE STOBBE - Associated Press Shares
European regulator finds “possible link” between Johnson & Johnson’s vaccine and very rare blood clo Associated Press Shares
COVID-19 cases rising despite half of adults in U.S. receiving their first vaccine By Tom Howell Jr. - The Washington Times Shares
Biden celebrates widespread vaccine eligibility: ‘You need to be protected’ By Tom Howell Jr. - The Washington Times Shares
J&J vaccine to remain in limbo while officials seek evidence By LAURAN NEERGAARD and MIKE STOBBE - Associated Press Shares
NC has 85,000 other vaccines for those with J&J appointments By BRYAN ANDERSON - Associated Press Shares
Missouri pauses use of Johnson & Johnson’s COVID-19 vaccine By HEATHER HOLLINGSWORTH - Associated Press Shares
